Mutations in SALL4 in malformed father and daughter postulated previously due to reflect mutagenesis by thalidomide

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 70, Issue 8, 2004, Pages 550-551

  Kohlhase, Jürgen ^b   Holmes, Lewis B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

THALIDOMIDE;

CONGENITAL MALFORMATION; DISEASE SEVERITY; DRUG EXPOSURE; EAR MALFORMATION; EMBRYOPATHY; EYE MALFORMATION; FEMALE; GENE; GENE MUTATION; HAND MALFORMATION; HOLT ORAM SYNDROME; HUMAN; HYPOPLASIA; KIDNEY MALFORMATION; LEG MALFORMATION; LETTER; LIMB MALFORMATION; MALE; MUTAGENESIS; PHENOTYPE; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; SALL4 GENE; THUMB MALFORMATION;

DUANE RETRACTION SYNDROME; FATHERS; FEMALE; HEARING LOSS; HUMANS; MALE; MUTATION; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; TERATOGENS; THALIDOMIDE; TRANSCRIPTION FACTORS;

EID: 4444246179     PISSN: 15420752     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdra.20050     Document Type: Letter

References (16)

1. Basson CT, Bachinsky DR, Lin RC, et al. 1997. Mutations in human cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet 15:30-35.
2. Holmes LB, Borden S. 1974. Phocomelia, flexion deformities and absent thumbs: a new hereditary upper limb malformation. Pediatrics 54:461-465.
3. Hurst JA, Hall CM, Baraister M. 1991. The Holt-Oram syndrome. J Med Genet 28:406-410.
4. Kajii T, Kida M, Takahashi K. 1973. The effect of thalidomide intake during 113 human pregnancies. Teratology 8:163-166.
5. Kohlhase J, Heinrich M, Schubert L, et al. 2002. Okihiro syndrome is caused by SALL4 mutations. Hum Mol Genet 11:2979-2987.
6. Kohlhase J, Schubert L, Liebers M, et al. 2003. Mutations at the SALL4 locus on chromosome 20 result in a range of clinically overlapping phenotypes, including Okihiro syndrome, Holt-Oram syndrome, acro-renal-ocular syndrome, and patients previously reported to represent thalidomide embryopathy. J Med Genet 40:473-478.
7. Lenz W, Knapp K. 1962. Die Thalidomid-Embryopathie. Dtsch Med Wochenschr 87:1232-1242.
8. Lenz W. 1992. The history of thalidomide (extract from a lecture given at the 1992 World Federation of Thalidomiders). (http://www.thalidomide.ca/en/ information/history_of_thalidomide.html).
9. Li QY, Newbury-Ecob RA, Terrett JA, et al. 1997. Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nat Genet 15:21-29.
10. McBride WG. 1994. Thalidomide may be a mutagen. Br Med J 308:1635-1636.
11. Miller MC, Strömland K. 1999. Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses. Teratology 60:306-321.
12. Poznanski AK, Gall JC Jr, Stern AM. 1970. Skeletal manifestations of the Holt-Oram syndrome. Radiology 94:45-53.
13. Read AP. 1994. Thalidomide may be a mutagen. Comment. Br Med J 308:1636.
14. Stiles KA, Dougan P. 1940. A pedigree of malformed upper extremities. J Hered 31:65-72.
15. Strömland K, Philipson E, Grönlund MA. 2002. Offspring of male and female parents with thalidomide embryopathy: birth defects and functional anomalies. Teratology 66:115-121.
16. van Bokhoven H, Hamel BC, Bamshad M, et al. 2001. p63 Gene mutations in EEC syndrome, limb-mammary syndrome, and isolated split hand-split foot malformation suggest a genotype-phenotype correlation. Am J Hum Genet 69:481-492.